Easywell Biomedicals, Inc. (TPEX:1799)

Taiwan · Delayed Price · Currency is TWD

29.00

+0.75 (2.65%)

Mar 5, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Drug Development Department	540.44M	271.63M	178.82M	191.97M	264.43M
Drug Development Department Growth	98.96%	51.90%	-6.85%	-27.40%	-25.80%
Other	-	-	79.00K	5.31M	3.22M
Other Growth	-	-	-98.51%	64.80%	-10.40%
Total	540.44M	271.63M	178.90M	197.28M	267.65M
Total Growth	98.96%	51.83%	-9.32%	-26.29%	-25.64%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United State	326.15M	271.63M	178.82M	191.97M	198.41M
United State Growth	20.07%	51.90%	-6.85%	-3.25%	-27.40%
Mainland China	214.17M	-	79.00K	-	-
Taiwan	119.00K	-	-	-	-
Asia	-	-	-	5.31M	69.25M
Asia Growth	-	-	-	-92.33%	-20.12%
Total	540.44M	271.63M	178.90M	197.28M	267.65M
Total Growth	98.96%	51.83%	-9.32%	-26.29%	-25.64%

Source: S&P Global Market Intelligence.